Based on recent reports, there are increasing concerns about the control of the scientific data obtained from clinical trials sponsored by industry. Many of the problems encountered are the result of restrictions contained in the research contracts that participating investigators are asked to sign. A number of solutions have been suggested to ensure the integrity of clinical trials, including the establishment of appropriately constituted trial oversight committees, negotiating noninterference pledges from industry sponsors, and creating proactive support of investigators' rights by organized medicine.
|Original language||English (US)|
|Number of pages||2|
|Journal||Archives of Surgery|
|State||Published - Jun 18 2002|
ASJC Scopus subject areas